{rfName}
Im

Indexed in

License and use

Altmetrics

Analysis of institutional authors

Pardo JcAuthorNotario LAuthorEtxaniz O.AuthorFont A.Corresponding Author
Share
Publications
>
Review

Immune Checkpoint Inhibitors: A Promising Treatment Option for Metastatic Castration-Resistant Prostate Cancer?

Publicated to:International Journal Of Molecular Sciences. 22 (9): 4712- - 2021-05-01 22(9), DOI: 10.3390/ijms22094712

Authors: de Porras, VR; Pardo, JC; Notario, L; Etxaniz, O; Font, A

Affiliations

Catalan Inst Oncol, Badalona Appl Res Grp Oncol B ARGO, Ctra Can Ruti Cami Escoles S-N, Badalona 08916, Spain - Author
Germans Trias & Pujol Res Inst IGTP, Ctra Can Ruti Cami Escoles S-N, Badalona 08916, Spain - Author
Germans Trias i Pujol Research Institute (IGTP) - Author
Hospital Universitari Germans Trias i Pujol - Author
Institute Catala Oncologia - Author
Univ Hosp Germans Trias & Pujol, Catalan Inst Oncol, Dept Med Oncol, Ctra Can Ruti Cami Escoles S-N, Badalona 08916, Spain - Author
See more

Abstract

Keywords
antitumor-activityctla-4double-blindimmune checkpoint inhibitorsimmunotherapyincreased survivalkeynote-365 cohortmitoxantrone plus prednisoneopen-labelpd-1pd-l1phase-iii trialregulatory t-cellssipuleucel-tAdenocarcinomaAdministration and dosageAntineoplastic agentAntineoplastic agents, immunologicalAntineoplastic combined chemotherapy protocolsAntineoplastic hormone agonists and antagonistsB7-h1 antigenBiological markerBiomarkersCancer hormone therapyCancer immunotherapyCancer resistanceCarrier proteinCastration resistant prostate cancerCd274 protein, humanClinical trial (topic)Clinical trials as topicCtla-4Cytotoxic t lymphocyte antigen 4Dna repairDrug effectDrug resistanceDrug resistance, neoplasmDrug therapyForecastingGeneticsHumanHumansImmune checkpoint inhibitorImmune checkpoint inhibitorsImmunological antineoplastic agentImmunotherapyMaleMembrane transport proteinsMetastatic castration resistant prostate cancerMetastatic castration-resistant prostate cancerMhc class-iMulticenter studies as topicMulticenter study (topic)Neoplasm proteinsNicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitorOrganoplatinum compoundsPd-1Pd-l1Pdcd1 protein, humanPersonalized medicinePlatinum complexPoly(adp-ribose) polymerase inhibitorsPrecision medicinePredictive valueProceduresProgrammed cell death 1 receptorProgrammed death 1 ligand 1Programmed death 1 receptorProstatic neoplasms, castration-resistantReviewSlc44a4 protein, humanTaxoidTaxoidsTreatment responseTumor markerTumor protein

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal International Journal Of Molecular Sciences due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2021, it was in position 69/297, thus managing to position itself as a Q1 (Primer Cuartil), in the category Biochemistry & Molecular Biology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 2.62, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions May 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-05-15, the following number of citations:

  • WoS: 15
  • Scopus: 15
Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-05-15:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 27.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 27 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.75.
  • The number of mentions on the social network X (formerly Twitter): 2 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.
Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (de Porras VR) and Last Author (Font Pous, Albert).

the authors responsible for correspondence tasks have been de Porras VR and Font Pous, Albert.